A target of thrombin activation promotes cell cycle re-entry by urodele muscle cells

Wound Repair and Regeneration

Volumn 6, Issue 4, 1998, Pages S‐371-S‐381

  Tanaka, Elly M ^a   Brockes, Jeremy P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; THROMBIN;

AMPHIBIA; ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CELL CULTURE; CELL CYCLE; CHROMATOGRAPHY; CULTURE MEDIUM; CYTOLOGY; FORELIMB; METABOLISM; MUSCLE; PHOSPHORYLATION; PHYSIOLOGY; REGENERATION;

ANIMALS; CATTLE; CELL CYCLE; CELLS, CULTURED; CHROMATOGRAPHY; CULTURE MEDIA; DNA; FORELIMB; MUSCLES; PHOSPHORYLATION; REGENERATION; THROMBIN; URODELA;

EID: 0032107607     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475x.1998.60413.x     Document Type: Article

References (41)

1. Nodder S, Martin P. Wound healing in embryos: a review. Anat Embryol (Berl) 1997;195:215-28.
2. Stocum DL. Wound repair, regeneration, and artificial tissues. Austin: RG Landes, 1995.
3. Hay ED. Electron microscopic observations of muscle dedifferentiation in regenerating Amblystoma limbs. Dev Biol 1959;1:555-85.
4. Steen TP. Stability of chondrocyte differentiation and contribution of muscle to cartilage during limb regeneration in the axolotl (Siredon mexicanum). J Exp Zool 1968;167:49-77.
5. Okada TS. Transdifferentiation: flexibility in cell differentiation. Oxford: Clarendon Press, 1991.
6. Lo DC, Allen F, Brockes JP. Reversal of muscle differentiation during urodele limb regeneration. Proc Natl Acad Sci USA 1993;90:7230-4.
7. Martin P. Wound healing: aiming for perfect skin regeneration. Science 1997;276:75-81.
8. Tanaka EM, Gann AA, Gates PB, Brockes JP. Newt myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein. J Cell Biol 1997;136:155-65.
9. Ferretti P, Brockes JP. Culture of newt cells from different tissues and their expression of a regeneration-associated antigen. J Exp Zool 1988;247:77-91.
10. Olwin BB, Hauschka SD. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. J Cell Biol 1988;107:761-9.
11. Clegg CH, Linkhart TA, Olwin BB, Hauschka SD. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 1987;105:949-56.
12. Hatakeyama M, Weinberg RA. The role of RB in cell cycle control. Prog Cell Cycle Res 1995;1:9-19.
13. Medema RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 1995;92:6289-93.
14. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995;375:503-6.
15. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal GB. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993;72:309-24.
16. Hamel PA, Gill RM, Phillips RA, Gallie BL. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol 1992;12:3431-8.
17. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
18. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-68.
19. Connell CL, Elledge SJ, Harper JW. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 1998;8:65-8.
20. Leng X, Connell CL, Goodrich D, Harper JW. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr Biol 1997;7:709-12.
21. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol Cell Biol 1998;18:753-61.
22. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994;9:3397-406.
23. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994;9:3389-96.
24. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
25. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
26. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-61.
27. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995;267:1018-21.
28. Franklin DS, Xiong Y. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 1996;7:1587-99.
29. Su JY, Rempel RE, Erikson E, Maller JL. Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1. Proc Natl Acad Sci USA 1995;92:10187-91.
30. Shou W, Dunphy WG. Cell cycle control by Xenopus p28Kix1, a developmentally regulated inhibitor of cyclin-dependent kinases. Mol Biol Cell 1996;7:457-69.
31. Lasorella A, Iavarone A, Israel MA. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol 1996;16:2570-8.
32. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
33. Colman R. Thrombosis and hemostasis. Philadelphia: Lippincott, 1993.
34. Hatzfeld JA, Hatzfeld A, Maigne J. Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA 1982;79:6280-4.
35. Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 1992;168:47-53.
36. Robson SC, Saunders R, de JC, Purves LR, Corrigall A, Kirsch RE. Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood 1993;81:3006-14.
37. Walz DA, Fenton JWII, Shulman MA. Bioregulatory functions of thrombin. Annals (Vol. 485). New York: New York Academy of Sciences, 1986.
38. Bradley WA, Song JN, Gianturco SH. Thrombin/prothrombin interactions with very low density lipoproteins. Ann NY Acad Sci 1986;485:159-69.
39. Pintucci G, Bikfalvi A, Klein S, Rifkin DB. Angiogenesis and the fibrinolytic system. Semin Thromb Hemost 1996;22:517-24.
40. Day FA, Neufeld DA. Use of enzyme overlay membranes to survey proteinase activity in frozen sections: cathepsin-like and plasmin-like activity in regenerating newt limbs. J Histochem Cytochem 1997;45:779-83.
41. McDonnell TJ, Oberpriller JO. The atrial proliferative response following partial ventricular amputation in the heart of the adult newt: a light and electron microscopic autoradiographic study. Tissue Cell 1983;15:351-63.